• <table id="gigg0"></table>
  • west china medical publishers
    Keyword
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Keyword "丙型病毒性肝炎" 3 results
    • The association between levels of serum leptin and hepatitis C virus: a meta-analysis

      ObjectivesTo systematically review the association between serum leptin level and hepatitis C virus.MethodPubMed, EMbase, Web of Science, CNKI, CBM, VIP and WanFang Data databases were electronically searched to collect case-control studies on the association between serum leptin level and hepatitis C virus from 2007 to July, 2017. Two reviewers independently screened literature, extracted data and assessed the risk of bias of included studies. Then, meta-analysis was performed by using RevMan 5.3 software.ResultsA total of 11 studies including 1 115 patients were included. The results of meta-analysis showed the serum leptin level was higher in hepatitis C patients than in healthy people (SMD=0.68, 95%CI 0.44 to 0.91, P<0.000 01). The results of subgroup analysis showed that, in hepatitis C patients whose serum leptin levels detected by RIA and European population, serum leptin levels were higher. Women had higher serum leptin levels than men in hepatitis C virus patients (P<0.000 01).ConclusionThe serum leptin level is associated with hepatitis C virus and the serum leptin levels of women are higher than those in men. Due to limited quantity and quality of the included studies, more high quality studies are required to verify above conclusions.

      Release date:2018-06-04 08:48 Export PDF Favorites Scan
    • 免疫檢查點抑制劑治療合并乙型肝炎或丙型肝炎的晚期非小細胞肺癌的安全性及療效分析

      目的 探討合并乙型肝炎或丙型肝炎的晚期非小細胞肺癌(non-small cell lung cancer,NSCLC)免疫檢查點抑制劑(immune checkpoint inhibitors,ICIs)治療的安全性和療效。方法 回顧性分析5例合并乙型肝炎或丙型肝炎的NSCLC,觀察谷丙轉氨酶(alanine aminotransferase,ALT)水平、病毒載量和總生存期。結果 1例活動性乙型肝炎和1例活動性丙型肝炎啟動ICIs治療時,ALT升高,加用抗病毒和保肝治療,ALT即恢復正常。2例活動性和1例慢性乙型肝炎ICIs治療,ALT持續正常水平。2例完全緩解,3例部分緩解,目前死亡2例,最長總生存期35.7個月,其余3例仍在隨訪中。結論 乙型肝炎或丙型肝炎不影響ICIs在NSCLC中的治療地位,包括在部分NSCLC的一線治療,全程監測肝功能和病毒拷貝數,推薦聯合抗病毒治療(特別對合并乙型肝炎),個體化調整抗病毒時機及療程。

      Release date:2023-01-18 06:43 Export PDF Favorites Scan
    • 丙型病毒性肝炎相關性冷球蛋白血癥二例

      Release date: Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南